Your browser doesn't support javascript.
loading
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto, Francisco J; Del Fresno, Carlos; Brandi, Paola; Combes, Alexis J; Hernández-García, Elena; Sánchez-Paulete, Alfonso R; Enamorado, Michel; Bromley, Christian P; Gomez, Manuel J; Conde-Garrosa, Ruth; Mañes, Santos; Zelenay, Santiago; Melero, Ignacio; Iborra, Salvador; Krummel, Matthew F; Sancho, David.
Afiliação
  • Cueto FJ; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Del Fresno C; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Brandi P; Hospital la Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Combes AJ; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Hernández-García E; Department of Pathology, University of California, San Francisco, California, USA.
  • Sánchez-Paulete AR; ImmunoX Initiative, University of California, San Francisco, California, USA.
  • Enamorado M; UCSF CoLabs, University of California, San Francisco, California, USA.
  • Bromley CP; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Gomez MJ; Division of Immunology and Immunotherapy, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
  • Conde-Garrosa R; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Mañes S; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Zelenay S; Cancer Inflammation and Immunity Group, CRUK Manchester Institute, The University of Manchester, Manchester, UK.
  • Melero I; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Iborra S; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Krummel MF; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin, Madrid, Spain.
  • Sancho D; Cancer Inflammation and Immunity Group, CRUK Manchester Institute, The University of Manchester, Manchester, UK.
J Immunother Cancer ; 9(5)2021 05.
Article em En | MEDLINE | ID: mdl-33980589
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Células Dendríticas / Melanoma Experimental / Receptores Imunológicos / Terapia Genética / Neoplasias do Colo / Lectinas Tipo C / Proteínas de Membrana Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Células Dendríticas / Melanoma Experimental / Receptores Imunológicos / Terapia Genética / Neoplasias do Colo / Lectinas Tipo C / Proteínas de Membrana Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido